Grant opportunity preview
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Offered by National Institutes of Health
HealthcareNationalOctober 20, 2027
Opportunity summary
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.